The U.S. National Institutes of Health (NIH) said data from the company’s trial of Gilead Sciences Inc.’s remdesivir show that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation.

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the program told Reuters.

AstraZeneca reported plans to manufacture as much as 30 million doses of the University of Oxford’s COVID-19 vaccine for the U.K. market by September 2020, with expectations of 100 million doses by the end of the year.

The U.S. Centers for Disease Control and Prevention (CDC) plans a nationwide study of up to 325,000 people to track how the new coronavirus is spreading across the country into 2021 and beyond, a CDC spokeswoman and researchers conducting the effort told Reuters.

Patients given the malaria drug touted by President Donald Trump as a potential treatment for COVID-19 did not improve significantly over those who did not, according to two new studies published in the medical journal BMJ .

Gilead Sciences entered into licensing agreements with five generic drugmakers to make the antiviral drug Veklury (remdesivir), the first medicine shown to be effective against COVID-19, available in 127 countries.

As the mortality figures for COVID-19 continued to rise, people are wondering where they will stop. The actual death toll for COVID-19 will not be calculable for some time, but there are early indications that the mortality rate may be significantly lower than calculations of deaths per confirmed cases lead one to believe.

A look at which parts of the body the novel coronavirus infects and how SARS-CoV-2 is transmitted from person to person.

Dr. Anthony Fauci – who has been considered one of the most trusted leaders tackling the COVID-19 pandemic in the United States – once again stressed that, as far as the evidence suggests, the novel coronavirus is naturally occurring and was not made in a laboratory.

Moderna Inc. and Swiss contract drugmaker Lonza Group AG said on Friday they would accelerate the manufacturing of the U.S. drug developer’s potential coronavirus vaccine.